trending Market Intelligence /marketintelligence/en/news-insights/trending/-n1r3eWuqmW_y4YyaMDPAQ2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Great Basin makes 510(k) submission to US FDA for whooping cough test

Blog

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Video

Climate Credit Analytics: Linking climate scenarios to financial impacts

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge


Great Basin makes 510(k) submission to US FDA for whooping cough test

Great Basin Scientific Inc. made a 510(k) submission to the U.S. FDA for its bordetella direct test.

The company's sample-to-result test detects bordetella pertussis, commonly known as whooping cough, identifying the bacterium behind the highly contagious respiratory disease.

Great Basin is also seeking a CE mark for the test.